Vera Therapeutics (VERA) Short Interest Ratio & Short Volume → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free VERA Stock Alerts $41.39 -0.55 (-1.31%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vera Therapeutics Short Interest DataCurrent Short Volume6,800,000 sharesPrevious Short Volume6,310,000 sharesChange Vs. Previous Month+7.77%Dollar Volume Sold Short$268.67 millionShort Interest Ratio / Days to Cover6.5Last Record DateApril 30, 2024Outstanding Shares54,700,000 sharesFloat Size40,940,000 sharesShort Percent of Float16.61%Today's Trading Volume447,100 sharesAverage Trading Volume1,202,787 sharesToday's Volume Vs. Average37% Short Selling Vera Therapeutics ? Sign up to receive the latest short interest report for Vera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVERA Short Interest Over TimeVERA Days to Cover Over TimeVERA Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Vera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,800,000 shares $268.67 million +7.8%16.6%6.5 $39.51 4/15/20246,310,000 shares $293.60 million -0.3%16.1%4.5 $46.53 3/31/20246,330,000 shares $272.95 million +1.4%16.1%4.9 $43.12 3/15/20246,240,000 shares $269.88 million +0.7%16.2%5.1 $43.25 2/29/20246,200,000 shares $291.90 million -8.4%16.5%5.3 $47.08 2/15/20246,770,000 shares $308.10 million +2.4%19.6%6.3 $45.51 Get the Latest News and Ratings for VERA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,610,000 shares $240.74 million +9.3%19.1%6.6 $36.42 1/15/20246,050,000 shares $114.65 million -3.7%21.5%10.3 $18.95 12/31/20236,280,000 shares $96.59 million +11.2%22.2%11.3 $15.38 12/15/20235,650,000 shares $90.40 million +5.6%20.0%10.7 $16.00 11/30/20235,350,000 shares $72.49 million +6.6%19.0%9.3 $13.55 11/15/20235,020,000 shares $67.07 million +1.2%17.8%8.5 $13.36 10/31/20234,960,000 shares $51.68 million -9.3%17.8%8.8 $10.42 10/15/20235,470,000 shares $58.20 million +11.9%19.9%10.7 $10.64 9/30/20234,890,000 shares $67.04 million +32.9%17.8%10.3 $13.71 9/15/20233,680,000 shares $62.89 million -2.9%13.4%7.3 $17.09 8/31/20233,790,000 shares $67.05 million +15.9%13.8%5.4 $17.69 8/15/20233,270,000 shares $57.85 million +6.2%11.9%4.7 $17.69 7/31/20233,080,000 shares $57.81 million -8.3%11.1%4.5 $18.77 7/15/20233,360,000 shares $56.92 million -2.6%12.3%5 $16.94 6/30/20233,450,000 shares $55.37 million -3.1%12.7%5.1 $16.05 6/15/20233,560,000 shares $45.28 million +24.5%13.4%5.6 $12.72 5/31/20232,860,000 shares $23.88 million -5.0%10.8%7.3 $8.35 5/15/20233,010,000 shares $23.99 million -9.1%11.3%7.5 $7.97 4/30/20233,310,000 shares $22.01 million +30.3%14.2%7.1 $6.65 4/15/20232,540,000 shares $15.93 million -28.9%9.7%4.6 $6.27 3/31/20233,570,000 shares $27.70 million +32.7%14.2%5.4 $7.76 3/15/20232,690,000 shares $19.18 million +15.5%10.7%3.2 $7.13 2/28/20232,330,000 shares $17.31 million +3.6%9.1%3 $7.43 2/15/20232,250,000 shares $17.71 million +47.1%8.8%3.1 $7.87 1/31/20231,530,000 shares $12.97 million +23.4%7.6%2.3 $8.48 1/15/20231,240,000 shares $8.36 million -12.1%9.3%2.4 $6.74 12/30/20221,410,000 shares $27.28 million -7.2%10.6%3.4 $19.35 12/15/20221,520,000 shares $29.14 million -22.1%11.4%11.7 $19.17 11/30/20221,950,000 shares $32.57 million -4.9%14.7%16 $16.70 11/15/20222,050,000 shares $34.54 million +15.8%15.5%18.9 $16.85 10/31/20221,770,000 shares $32.99 million +10.6%14.7%18.1 $18.64 10/15/20221,600,000 shares $30.69 million -1.2%13.3%18.6 $19.18 9/30/20221,620,000 shares $34.52 million +14.9%13.4%18.8 $21.31 9/15/20221,410,000 shares $30.13 million -10.2%11.7%16.2 $21.37The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. VERA Short Interest - Frequently Asked Questions What is Vera Therapeutics' current short interest? Short interest is the volume of Vera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 6,800,000 shares of VERA short. 16.61% of Vera Therapeutics' shares are currently sold short. Learn More on Vera Therapeutics' current short interest. What is a good short interest ratio for Vera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERA shares currently have a short interest ratio of 6.0. Learn More on Vera Therapeutics's short interest ratio. Which institutional investors are shorting Vera Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vera Therapeutics: StemPoint Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.61% of Vera Therapeutics' floating shares are currently sold short. Is Vera Therapeutics' short interest increasing or decreasing? Vera Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 6,800,000 shares, an increase of 7.8% from the previous total of 6,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vera Therapeutics' float size? Vera Therapeutics currently has issued a total of 54,450,000 shares. Some of Vera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vera Therapeutics currently has a public float of 40,940,000 shares. How does Vera Therapeutics' short interest compare to its competitors? 16.61% of Vera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vera Therapeutics: Geron Co. (8.82%), Arvinas, Inc. (12.65%), Zai Lab Limited (4.39%), Rocket Pharmaceuticals, Inc. (10.84%), Amneal Pharmaceuticals, Inc. (2.31%), Deciphera Pharmaceuticals, Inc. (11.65%), PTC Therapeutics, Inc. (12.95%), Indivior PLC (0.14%), ACADIA Pharmaceuticals Inc. (7.28%), Dyne Therapeutics, Inc. (18.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Vera Therapeutics stock? Short selling VERA is an investing strategy that aims to generate trading profit from Vera Therapeutics as its price is falling. VERA shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vera Therapeutics? A short squeeze for Vera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VERA, which in turn drives the price of the stock up even further. How often is Vera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GERN Short Interest ARVN Short Interest ZLAB Short Interest RCKT Short Interest AMRX Short Interest DCPH Short Interest PTCT Short Interest INDV Short Interest ACAD Short Interest DYN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VERA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders